318 related articles for article (PubMed ID: 29801504)
1. Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma.
Song Y; Kim JS; Kim SH; Park YK; Yu E; Kim KH; Seo EJ; Oh HB; Lee HC; Kim KM; Seo HR
J Exp Clin Cancer Res; 2018 May; 37(1):109. PubMed ID: 29801504
[TBL] [Abstract][Full Text] [Related]
2. Activated hepatic stellate cells play pivotal roles in hepatocellular carcinoma cell chemoresistance and migration in multicellular tumor spheroids.
Song Y; Kim SH; Kim KM; Choi EK; Kim J; Seo HR
Sci Rep; 2016 Nov; 6():36750. PubMed ID: 27853186
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Na
Song Y; Lee SY; Kim S; Choi I; Kim SH; Shum D; Heo J; Kim AR; Kim KM; Seo HR
Sci Rep; 2020 Mar; 10(1):5318. PubMed ID: 32210281
[TBL] [Abstract][Full Text] [Related]
4. Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.
Song Y; Kim S; Heo J; Shum D; Lee SY; Lee M; Kim AR; Seo HR
Sci Rep; 2021 May; 11(1):10931. PubMed ID: 34035369
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytes.
Jang JW; Song Y; Kim KM; Kim JS; Choi EK; Kim J; Seo H
BMC Cancer; 2016 Oct; 16(1):810. PubMed ID: 27756242
[TBL] [Abstract][Full Text] [Related]
7. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
8. Cell Spheroids with Enhanced Aggressiveness to Mimic Human Liver Cancer In Vitro and In Vivo.
Jung HR; Kang HM; Ryu JW; Kim DS; Noh KH; Kim ES; Lee HJ; Chung KS; Cho HS; Kim NS; Im DS; Lim JH; Jung CR
Sci Rep; 2017 Sep; 7(1):10499. PubMed ID: 28874716
[TBL] [Abstract][Full Text] [Related]
9. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma.
Khawar IA; Park JK; Jung ES; Lee MA; Chang S; Kuh HJ
Neoplasia; 2018 Aug; 20(8):800-812. PubMed ID: 29981501
[TBL] [Abstract][Full Text] [Related]
10. A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinoma.
Hou J; Hong Z; Feng F; Chai Y; Zhang Y; Jiang Q; Hu Y; Wu S; Wu Y; Gao X; Chen Q; Wan Y; Bi J; Zhang Z
BMC Cancer; 2017 Nov; 17(1):729. PubMed ID: 29117859
[TBL] [Abstract][Full Text] [Related]
11. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
12. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
Yang S; Wang XQ
BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
[TBL] [Abstract][Full Text] [Related]
13. Chinese medicinal compound delisheng has satisfactory anti-tumor activity, and is associated with up-regulation of endostatin in human hepatocellular carcinoma cell line HepG2 in three-dimensional culture.
Cui J; Nan KJ; Tian T; Guo YH; Zhao N; Wang L
World J Gastroenterol; 2007 Nov; 13(41):5432-9. PubMed ID: 17907285
[TBL] [Abstract][Full Text] [Related]
14. Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells.
Lo Re O; Panebianco C; Porto S; Cervi C; Rappa F; Di Biase S; Caraglia M; Pazienza V; Vinciguerra M
J Cell Physiol; 2018 Feb; 233(2):1202-1212. PubMed ID: 28471474
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of vascular endothelial growth factor inhibitor sunitinib in preclinical models of hepatocellular carcinoma.
Bagi CM; Gebhard DF; Andresen CJ
Eur J Gastroenterol Hepatol; 2012 May; 24(5):563-74. PubMed ID: 22314934
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models.
Kim S; Lee SY; Seo HR
BMB Rep; 2023 Apr; 56(4):225-233. PubMed ID: 36814078
[TBL] [Abstract][Full Text] [Related]
17. Short exposure to millimolar concentrations of ethanol induces apoptotic cell death in multicellular HepG2 spheroids.
Castañeda F; Kinne RK
J Cancer Res Clin Oncol; 2000 Jun; 126(6):305-10. PubMed ID: 10870639
[TBL] [Abstract][Full Text] [Related]
18. Applicability of tumor spheroids for
Hamilton G; Rath B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
[No Abstract] [Full Text] [Related]
19. High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.
Kochanek SJ; Close DA; Johnston PA
Assay Drug Dev Technol; 2019 Jan; 17(1):17-36. PubMed ID: 30592624
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
